Meropenem Arrow Lab

Meropenem, the active ingredient in Meropenem Arrow Lab, is a carbapenem antibiotic presented as a strength/form for intravenous use. It treats serious bacterial infections, including intra‑abdominal, urinary, respiratory, and central nervous system infections, in hospitalized patients.

GNH USA supplies Meropenem Arrow Lab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used for severe bacterial infections in the hospital setting.

- Complicated intra‑abdominal infections: provides bactericidal activity against mixed flora causing intra‑abdominal sepsis. - Complicated urinary tract infections: eradicates resistant Gram‑negative and Gram‑positive pathogens in the urinary tract. - Hospital‑acquired pneumonia: treats pneumonia caused by multidrug‑resistant organisms acquired in healthcare settings. - Ventilator‑associated pneumonia: effective against pathogens colonizing the respiratory tract of ventilated patients. - Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis. - Severe sepsis: offers rapid bacterial clearance in systemic infection.

Adverse reactions may occur with meropenem therapy and should be monitored.

Common Side Effects: - Diarrhea: mild to moderate gastrointestinal upset. - Nausea: occasional feeling of queasiness. - Headache: transient cranial discomfort. - Rash: mild skin erythema or pruritus. - Elevated liver enzymes: transient increase in hepatic transaminases. - Phlebitis at infusion site: irritation of peripheral veins.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Seizures: especially in patients with renal impairment or CNS disease. - Clostridioides difficile colitis: severe colonic infection. - Hemolytic anemia: rare immune‑mediated red cell destruction. - Renal toxicity: acute kidney injury in susceptible individuals. - Stevens‑Johnson syndrome: severe mucocutaneous reaction.

Meropenem should be used with caution and under professional supervision.

- Renal function: adjust dose in patients with impaired kidney function. - Seizure risk: monitor neurologic status, especially in patients with CNS disorders. - Allergies: avoid in individuals with known carbapenem or beta‑lactam hypersensitivity. - Pregnancy and lactation: use only if benefit outweighs potential risk. - Drug interactions: review concomitant medications for potential interactions. - Storage: Store at ambient temperature: keep in original container, protect from moisture and light.

Meropenem may interact with other medicines; awareness of interaction severity is essential.

Major Interactions (Avoid): - Valproic acid: may reduce serum levels, risking seizure breakthrough. - Probenecid: can increase meropenem concentrations, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxicity; monitor renal function. - Loop diuretics: may enhance ototoxic potential when combined with other ototoxic agents. - Anticoagulants: possible alteration of INR; check coagulation parameters regularly.